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Abstract 
Background/Objectives: A combined heart rate (HR) and motion sensor (Actiheart®) has been 
proposed as an accurate method for assessing total (TEE) and physical activity energy expenditure 
(PAEE). However the extent to which factors such as caffeine may affect the accuracy by which the 
estimated HR-related PAEE contribution will affect TEE and PAEE estimates is unknown. Therefore, 
we examined the validity of Actiheart® in estimating TEE and PAEE in free-living adults under a 
caffeine trial compared with doubly labeled water (DLW) as criterion.  
Subjects/Methods: Using a double-blind crossover trial (ClinicalTrials.govID: #NCT01477294) with 
two conditions (4-day each with a 3-day washout period) randomly ordered as caffeine (5mg/kg/day) 
and placebo (malt-dextrine) intake, TEE was measured by DLW in 17 physically active males (20-38 
years), non-caffeine users. In each condition, resting energy expenditure (REE) was assessed by 
indirect calorimetry and PAEE calculated as [TEE-(REE+0.1TEE)]. Simultaneously, PAEE and TEE 
were estimated by Actiheart® using an individual calibration (ACC+HRstep).  
Results: Under caffeine, ACC+HRstep explained 76% and 64% of TEE and PAEE from DLW, 
respectively; corresponding results for the placebo condition were 82% and 66%. No mean bias was 
found between ACC+HRstep and DLW for TEE (caffeine:468 kJ/day; placebo:407 kJ/day) though 
PAEE was slightly underestimated (caffeine:-856 kJ/day; placebo:-1150 kJ/day). Similar limits of 
agreement were observed in both conditions ranging from -2066 to 3002 and from -3488 to 1776 
kJ/day for TEE and PAEE.  
Conclusions: Regardless of caffeine intake, the combined HR and motion sensor is valid for estimating 
free-living energy expenditure in a group of healthy males but is less accurate for an individual 
assessment.  
Key Words: Physical Activity; Indirect calorimetry; Heart rate monitoring, Accelerometry; Methods 
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Introduction  
Adequately measuring physical activity (PA) is important for determining trends in PA levels over 
time, for evaluating the effect of PA interventions and for determining PA health benefits. Poor 
measurement of PA may hinder detection of important associations or effects. In fact energy 
expenditure resulting from PA (PAEE) may differ substantially and an accurate assessment is 
determinant to established dose-response relationship with health outcomes. Indeed, higher levels of 
PAEE have been reported to decrease the risk of all-cause mortality in elderly people1, blood pressure 
in adults2, abdominal obesity3, and risk of weight gain4, 5. Nevertheless, the amount of PAEE required 
for disease prevention and health promotion remains unclear given the intrinsic difficulties in assessing 
the intensity, duration, and frequency of all types of activities during free-living condition in large 
population studies6.  
The doubly labeled water (DLW) method is the most accurate method for measuring total energy 
expenditure (TEE) in free-living conditions. Unfortunately, this method is expensive and requires a 
specialized laboratory for sample analysis. Indeed the DLW technique is a stable isotope technique 
used for determining human energy metabolism of healthy and clinical populations through biological 
markers7. Combined with the measurement of resting energy expenditure (REE) this technique is 
considered the criterion measure of PAEE in free-living individuals. Due to the confinement and 
intrusiveness of direct calorimetry and the cost of DLW, objective methods such as heart rate (HR) 
monitoring and accelerometers, have been developed to estimate TEE and PAEE. While the latter has 
been shown to considerably underestimate PA given the accelerometers limitations in capturing several 
activities8 the evaluation of PA based on HR relies on a linear HR and physical activity intensity (PAI) 
relationship. This relationship is known to vary according to age, sex, and fitness level and an 
individual calibration is required9. A new generation of PA motion sensors that combines an 
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accelerometer with a HR monitor has been suggested by many to offer greater measurement validity of 
PA than either method used in isolation9-14. So far only two studies assessed the validity of a 
commercially available device (Actiheart, CamNtech Limited, UK). Using participants of rural and 
urban areas Assah et al14 found no significant mean bias between PAEE estimated from the combined 
monitor or measured by DLW in free-living conditions. Recently, Villars et al10 observed a good level 
of agreement between the Actiheart® estimates and DLW-measured PAEE in lean and overweight men 
with varying fitness levels, including the changes in free-living PAEE in response to an exercise 
intervention.  
While combining HR monitoring to movement registration improves the validity of PAEE estimates, 
difficulties in accurately evaluate HR may also compromise PAEE assessment. For instances, the 
previous mentioned linear HR-PAI relationship may also be dependent on the use of ergogenic 
substances, such as caffeine, that is proposed to act by increasing sympathomimetic activity (and thus 
heart rate)15. As a result, the advantage of obtaining PAEE by adding HR measures to a motion sensor 
may be also dependent on the accuracy by which the estimated HR-related PAEE contribution is 
independent of expected increases in sympathomimetic activity. Hence, the validity of this combined 
monitor in accurately assessing TEE and PAEE under the effect of a moderate dose of caffeine intake 
in non-regular users is still unknown. 
The aim of this study was to analyze the validity of the combined monitor in estimating TEE and PAEE 
in free-living male adults during a double-blind crossover caffeine trial compared with doubly labeled 
water (DLW) as the reference method. 
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Methods 
Participants 
A total of 30 healthy non-smoking males, recruited through advertisements around the institution, 
volunteered to participate in this study, as described in the Consort flow diagram16 (Figure 1). 
Participants were non-athletes and were engaged in daily general fitness activities up to 2 h. Inclusion 
criteria were: age 20-39 years; body mass index (BMI) 18.5-29.9 kg/m2; not taking any medication or 
dietary supplement; physically active, defined as ≥30 minutes/day of moderate to vigorous PA, 
according to the recommendations of the World Health Organization and corresponding policy actions 
for the promotion of PA17; and low-caffeine users (<100 mg/day)18. The daily consumption of caffeine 
was estimated based on a 7-day self-report of the daily intakes of coffee, tea, caffeinated sodas, 
chocolate, and other dietary sources, according to a list provided by two sources19, 20. All participants 
were informed about the possible risks of the investigation before giving their written informed consent 
to participate. All procedures were approved by the ethics Committee of the Faculty of Human 
Kinetics, Technical University of Lisbon, and were conducted in accordance with the declaration of 
Helsinki for human studies21. 
*Figure-1* 
 
Experimental Design 
Participants were enrolled in a double-blind crossover experiment with two conditions administered in 
random order: caffeine (5 mg/kg/day) and malt-dextrin as placebo, both through capsules. 
Caffeine/placebo conditions were randomized by an automated computer-generated randomization 
scheme and assigned to specific study days. Staff involved on data collection and capsules deliver as 
well as participants and were blinded to the condition allocation. A laboratorial technician, responsible 
6 
 
for preparation of the doses, was the only person aware of the randomization code during the trial. Each 
condition lasted for 4 days and participants were instructed to keep the same eating patterns and level 
of PA. There was a washout period of 3 days between each condition22. Moreover, to reduce the 
variability of individual PA patterns during the week, both conditions were performed on the same 
weekdays while the washout period always included the weekend days. Evaluations occurred from 
January to March 2011 and were performed at 3 time points: 1): first visit: baseline data collection; 2) 
second visit: 4 days after baseline, for collecting the final measurements of the first randomly assigned 
condition (placebo or caffeine); and 3) third visit: 7 days after the end of the second condition, 
including the 3-day washout period, for collecting the final measurements of the second randomly 
assigned condition (placebo or caffeine). 
Participants were required to fast for at least 12 h prior to each visit, refrain from vigorous exercise for 
at least 15 h, refrain from caffeine and alcohol consumption for 24 h, and consume a normal evening 
meal the night before the visit. All measurements were carried out in the morning of the same week 
day. In brief, the procedures are described as follows: 
 
Caffeine and placebo intake 
After weighing the participants, the dose was individually prepared to assure that a 5 mg of caffeine/kg 
of body mass/day was administered. The dose of caffeine was divided into two equal parts (2.5 mg/kg, 
specifically divided in labeled containers) to be orally consumed through capsules in the morning and 
after lunch. An equivalent dose (5 mg/kg/day) and number of placebo capsules, of the same color as the 
caffeine capsules, containing malt-dextrin were provided for the placebo condition. Daily phone calls 
to participants ensured compliance with treatment conditions.   
 
7 
 
Anthropometry 
Subjects wearing a bathing suit and without shoes were weighed to the nearest 0.01 kg on an electronic 
scale connected to a plethysmograph computer (BOD POD®, COSMED, Rome, Italy). Height was 
measured to the nearest 0.1 cm with a stadiometer (Seca, Hamburg, Germany) according to the 
standardized procedures described elsewhere23. 
 
Fat mass (FM) and fat free mass (FFM) 
A dual energy X-ray absorptiometry whole-body scan was used to estimate FM and FFM (Hologic 
Explorer-W, fan-beam densitometer, software QDR for windows version 12.4, Waltham, USA). Based 
on test-retest using ten subjects, the coefficient of variation (CV) for the FM and FFM are 1.7% and 
0.8%, respectively24. 
 
Resting Energy Expenditure (REE) assessed by indirect calorimetry 
REE was assessed in the morning in the same room at an environmental temperature and humidity of 
±22ºC and 40-50% respectively. The MedGraphics CPX Ultima (Medical Graphics Corp, St Paul, MN, 
with Breeze suite software) indirect calorimeter was used to measure breath by breath oxygen 
consumption (?̇?𝑉O2) and carbon dioxide production (?̇?𝑉CO2) using a facial mask. Participants lay down 
supine for 30 minutes and the calorimeter device was then attached to the mask for collecting breath by 
breath ?̇?𝑉O2 and ?̇?𝑉𝐶𝐶O2 during an additional 30-min. The first and the last 5-min of data collection were 
discarded and the mean of a 5-min steady state interval between the 5 and the 25 minute with RQ 
between 0.7 and 1.0 was used to calculate REE. Steady state was defined as a 5-min period with ≤10% 
CV for ?̇?𝑉O2 and VCO225. Mean ?̇?𝑉O2 and ?̇?𝑉CO2 of 5-min steady states were used in Weir’s equation26 
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with the lowest REE period considered. The CV for REE, based on test-retest using 7 young active 
adults, was 4.0 %27.  
 
Total energy expenditure (TEE) from doubly labeled water 
TEE was measured by an established procedure using deuterium oxide and 18-Oxygen28. Doubly 
labeled water (DLW) was administered in the morning of the first visit (baseline). Briefly, subjects 
were weighed in the morning and baseline urine was collected. An oral dose of 2.7 g/kg of TBW of a 
10 atom% (AP) solution of H218O (Taiyo Nippon Sanso Corporation, Tokyo, Japan), assuming that 
TBW is 0.61xbody mass, and 0.24 g/kg of TBW of a 99.9 AP solution of 2H2O (Sigma-Aldrich, Co, St 
Louis, Mo, USA), diluted in 50 ml of water and administered to the subjects at 7.00 a.m.. Post-dose 
urine samples of the first visit day were taken and stored from voids at 4 and 5 hours. Morning urine 
samples and 1hour after were collected on day 4 (end of first condition), after the washout period (day 
7), and at the end of the second condition (last day). Urine samples were prepared and filled with the 
equilibration gas. The equilibration period lasted for 3 days and 8h, respectively for 2H and 18O. 
Samples were analyzed in duplicates and calibrated against standard mean ocean water (SMOW), using 
Hydra isotope ratio mass spectrometer (PDZ, Europa Scientific, UK). A two-point sample method was 
used to evaluate the elimination constants (kd and ko, respectively for deuterium and 18-oxygen) over 
the first and the second 4-day periods (condition 1 and 2, respectively). For analyzing condition 2, 
urine samples collected after the washout period (day 7) and on the last day of the trial (day 11) were 
considered to evaluate the elimination constants. A similar procedure was used elsewhere29. TEE by the 
DLW method was calculated from a modified Weir's equation, including the food quotient obtained by 
dietary intake records26. The CV for TEE, based on test-retest using 10 elite athletes, was 4.3 %27. 
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PAEE was calculated as the difference between TEE and the sum of REE with 0.1xTEE (assuming the 
thermic effect of food is ~10% of TEE) while physical activity level (PAL) was determined as the ratio 
between TEE to REE. 
 
Dietary-record analysis 
Food intake was assessed throughout the trial using 24-h diet records. Participants were instructed 
regarding portion sizes, food preparation methods, and others aspects pertaining to an accurate 
recording of their food intake. Accuracy of the food intake recordings was ascertained by the study 
nutritionist at the second study visit (4 days after baseline). At the last visit, records were turned in and 
reviewed for macronutrient composition and energy intake. Diet records were analysed using a 
software package (Food Processor SQL, ESHA Research Salem, OR, USA).  
 
Energy expenditure (EE) from combined HR and motion sensor 
EE were evaluated using a combined HR and motion sensor monitor (Actiheart, CamNtech Limited, 
UK). The monitor was worn on a polar band placed on the chest. Initially, participants performed an 8-
min step test at a step height of 215 mm, the stepping speed ramps linearly increased from 15 to 33 step 
cycles/min. Step test provided individual calibration of HR-PAI. Subsequently, the device was started 
at the long term mode to record HR and acceleration with 60-sec epochs. The participants were asked 
to wear the monitor at all times throughout the trial, along with the DLW assessment. 
Data from the monitors were downloaded into to the commercial software (version 4.0.99). The 
camNtech software algorithm allowed data cleaning, recovering, and interpolation of missing and noisy 
HR. 
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PAEE was estimated, separately for the caffeine and placebo condition, using different energy models, 
available in the commercial software (Actiheart software version 4.0.99, CamNtech Limited, UK):  
ACC+HRstep: using the individual HR calibration model (Group Cal JAP2007/StepHR30), with HR and 
accelerometry data; 
ACC+HRgroup: using the group HR calibration model (Group Cal JAP200730) with HR and 
accelerometry data; 
HRflex: using the individual HR calibration model (Group Cal JAP2007/StepHR30), with HR data; 
ACC: using accelerometry data. 
Overall, Actiheart counts and HR data are initially used to estimate separate acceleration and HRflex 
models. The counts are converted to ACC-PAEE estimates using group-calibrated accelerometry 
equations derived from walking and running accelerations in studies conducted with the Actiheart30. 
The HRflex was estimated with a sleeping HR-based regression equation13 while the related PAEE 
assessment was calculated using the individual calibrated HR-PAEE relationships above the HRflex 
(established at 0 for minutes below that point). Then, minute-by-minute HR- and ACC-PAEE estimates 
were combined in a branched equations model to calculate daily PAEE as described elsewhere30. In the 
branched equations model, the relative contribution of accelerometry and HR for PAEE estimation is 
weighted epoch by epoch according to different counts and HR thresholds. Briefly, when both ACC 
and HR values are low, the ACC–PAEE estimates have more weight, while when ACC and HR values 
are high, the HR–PAEE estimates are the predominant contributor to the minute-by-minute PAEE 
estimates.  
The TEE was estimated by adding to the PAEE the thermic effect of food (~10% of TEE) and the REE, 
estimated using the Schofield equation31, as suggested by the commercial software. 
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Statistical Analysis 
Descriptive statistics including means and standard deviations (SD) were calculated for all outcome 
measurements. Normality was tested using Shapiro–Wilk test. Comparisons between methods were 
analysed using paired sample T-test or the non-parametric Wilcoxon test. 
Simple linear regressions were performed to calculate the relationship between TEE and PAEE 
estimated by the reference DLW method and the combined monitor models. 
The concordance coefficient correlation (CCC) was analysed to evaluate the degree to which pairs of 
observations fall on the 45º line through the origin32. The CCC (ρc) contains a measurement of 
precision ρ and accuracy (ρc=ρCb) where ρ is the Pearson correlation coefficient, which measures how 
far each observation deviates from the best-fit line, and is a measure of precision, and Cb is a bias 
correction factor that measures how far the best-fit line deviates from the 45º line through the origin, 
and is a measure of accuracy. 
Agreement between methods was assessed33, including the 95% limits of agreement, including the 
trend between the mean and the difference of both methods. 
Data analysis was performed using IBM SPSS Statistics version 19.0, 2010 (SPSS Inc., an IBM 
Company, Chicago, Illinois, U.S.A.) and the MedCalc Statistical Software version 11.1.1.0 (MedCalc 
Software, Mariakerke, Belgium). For all tests, statistical significance was set at p<0.05. 
The sample size estimated for the primary outcome of this clinical trial (effects of caffeine on EE) was 
calculated based on prior normally distributed data on EE mean differences of 322 kJ/day with a 
standard deviation of 502 kJ/day34. To reject the null hypothesis that this difference is zero with a 
power of 80% and a type I error probability of 0.05, 21 pairs of participants were necessary. To assure 
that drop-outs or equipment/technique failure would not compromise our results we enrolled 30 
participants. 
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Results 
The participant’s characteristics are shown in table 1.  
 
*Table-1* 
 
The mean and standard deviations for HR, REE, TEE, and PAEE from the reference and alternative 
methods are summarized in table 2. 
 
*Table-2* 
 
Under both conditions, TEE values from HRflex significantly overestimated the DLW method, while an 
underestimation was observed for the ACC model. The PAEE was underestimated using the individual 
calibration (ACC+HRstep) under placebo and the ACC whereas using the HRflex model the reference 
method was overestimated. 
We further tested if the order of treatment both as a main effect and its interaction with each EE models 
explained the variability of the reference TEE and PAEE values, under placebo and caffeine treatment 
conditions. Neither the order of treatment nor the interaction terms were significant predictors of the 
reference PAEE and TEE, for both conditions. 
Accuracy and agreement of the combined monitor in estimating TEE and PAEE from the reference 
method under both conditions are presented in tables 3 and 4.  
 
*Tables-3 and4* 
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Under placebo treatment, the combined monitor models explained between 43% (ACC) to 82% 
(ACC+HRstep) of TEE values obtained from DLW whereas for PAEE the monitor explained between 
17% (ACC) and 66% (ACC+HRstep) of the variability in the PAEE values obtained from the reference 
method. During caffeine treatment, the combined monitor models explained between 50% (ACC) to 
76% (ACC+HRstep) of the TEE values obtained from DLW. For PAEE the monitor explained between 
39% (ACC) to 53% (ACC+HRstep and HRflex) of the variance in the reference PAEE values.  
The higher CCC values were obtained for the ACC+HRstep model, ranging from 0.67 (PAEE) to 0.89 
(TEE) under placebo and from 0.71 (PAEE) to 0.84 (TEE) during the caffeine treatment. Lower CCC 
values were observed for the ACC model, ranging from 0.10 (PAEE) to 0.33 (TEE) under placebo and 
from 0.13 (PAEE) to 0.32 (TEE) during caffeine intake.  
For both conditions, lower limits of agreement were found for TEE and PAEE values obtained by the 
ACC+HRstep model with no trend between the mean and the difference of the methods. Figure 2 
displays the regression analysis and Bland-Altman plots for PAEE values assessed by the ACC+HRstep 
model and the criterion method, under both conditions. 
*Figure-2* 
We further tested the sensitivity of the ACC+HRstep model in detetcting changes occurred in PAEE 
from placebo to caffeine condition using DLW as the reference. The changes in PAEE estimated by the 
monitor explained 45% of the variability of the PAEE changes from DLW with a standard error of 
estimation of 1520 kJ/day. The slope (0.848) and intercept (181) did not differ from 1 and 0, respectively. 
The CCC value was 0,64 (precision of 0.67 and accuracy of 0.96) and the limits of agreement ranged 
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from -3212 to 2631 kJ/day with no trend (r=-0.308, p=0.229) between the mean and the difference of the 
methods. 
Discussion 
This is the first study to address the validity of a combined HR and motion sensor monitor in assessing 
EE during a double-blind crossover caffeine trial using DLW as the reference criteria. Given the 
limitations of relying on either HR or accelerometer only to estimate TEE and PAEE, this device is a 
new generation of PA monitors that combines both measurements. Therefore this study tested the 
extent to which factors such as a moderate dose of caffeine in non-regular users would affect the 
accuracy by which the estimated HR-related PAEE contribution would affect TEE and PAEE 
estimates. 
Regardless of caffeine or placebo intake and order of treatment, TEE values from the ACC+HRstep did 
not differ from DLW whereas a slight underestimation was found for PAEE under the placebo condition. 
It should be noted that this result may be due to a previously-found underestimation (~800kJ/day) of 
REE using the MedGraphics CPX Ultima in relation to Deltatrac Metabolic Monitor (VIASYS 
Healthcare Inc, SensorMedics, Yorba Linda, CA), one of the most popular indirect calorimetry systems 
for measuring resting metabolic rate in human subjects35. If in fact REE is being underestimated, a 
resulted overestimation of PAEE is expected when using the combined DLW and indirect calorimetry 
techniques. Therefore, if higher REE and lower PAEE would have been observed from the criterion 
method, the true PAEE calculated from DLW would be lower and closer to the Actiheart predicted PAEE 
values, instead of showing a considerable underestimation. The HRflex and the ACC model over and 
underestimated both TEE and PAEE values in both conditions. The models were significantly related 
with the reference DLW values in estimating TEE and PAEE, with the exception of the ACC model. We 
further observed that both for TEE and PAEE, the individual calibration combined model was overall 
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more accurate and precise whereas the accelerometry-based model was the least accurate and precise in 
estimating TEE and PAEE from DLW. 
So far, only two studies10, 14 tested the validity of this particular combined monitor (Actiheart) in free-
living conditions used DLW as the reference method. In fact, our findings seem to extend those 
observed by Villars et al10 that tested the validity of the combined ACC and HR in estimating PAEE in 
11 lean active, 12 lean sedentary, and 12 overweight sedentary participants aged 18-55 years. 
According to this study PAEE estimates based on both recordings combined in a weighed branched 
model correlate better with DLW reference measures in free-living conditions than estimates from HR 
or ACC alone. Using the group calibrated equations the agreement in estimating PAEE from the 
reference method is modest but when the authors used the individual calibration of the HR, an 
improved PAEE prediction of the combined model was observed, accounting for 71% of the total 
variance in the reference method, with no significant bias and a reduction by one-third of the standard 
error of estimation. On the other hand, Assah et al14 analysed the accuracy of the Camtech combined 
monitor in rural and urban participants during free-living conditions using DLW as the reference 
criterion. The authors observed a significantly higher PAEE in rural compared to urban participants, 
reporting higher associations between methods for urban participants, ranging from 0.40 (for HRflex) to 
0.70 (for ACC) in urban and from 0.25 (for HRflex) to 0.45 in rural (for ACC). Our results suggested 
stronger associations between the combined monitor with DLW ranging from 0.04 (for ACC) to 0.90 
(for ACC+HRstep) under placebo and from 0.58 (for ACC) to 0.86 (for ACC+HRstep) under caffeine.  
Agreement analysis indicated a non-significant trend between the mean and the difference of the methods 
in estimating TEE and PAEE for the ACC+HRstep. However for the remaining models, specifically HRflex 
and ACC, a significant association between the difference and the mean of the methods was observed 
meaning that the magnitude of the combined monitor error is dependent on the individual TEE and 
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PAEE, when using these EE models. These findings are in accordance with those reported by Assah et 
al14 that observed less accurate results in the rural sub-sample with higher TEE and PAEE. Using group 
calibration these authors14 reported a non-significant mean bias between PAEE between the combined 
monitor and the reference method with limits of agreement similar to ours. However PAEE from the 
combined sensor only accounted for 16% of the variance in the combined DLW and indirect calorimetry 
for PAEE assessment. In fact our findings are close to those reported by Villars et al10 that observed a 
better accuracy and agreement between the individual calibration model and the reference method. It is 
possible that the higher correlations observed in our study and the data reported by Villars et al10 could 
be related to the similar characteristics of the sample living in an European urban environment, favouring 
more acceleration-dependent and less weight bearing activities than rural participants. In fact Assah et 
al14 did report a better accuracy for the participants living in the urban sub-Saharan area.  
Regardless of caffeine consumption, tighter limits of agreement for TEE and PAEE were observed using 
ACC+HRstep whereas the ACC model displayed wider limits of agreement. The significant 
underestimation of both TEE and PAEE and the poor individual accuracy observed for the ACC model 
is in accordance with the findings reported by Brage et al30 suggesting that PA intensity is 
underestimated, mainly due to the variability of the sources of movement and the assumptions about the 
efficiency of the work performed. It is expected that accelerometers underestimate EE as the linearity 
between counts and aerobic intensity cannot always be assumed at moderate to high velocities36. Previous 
studies observed that the accelerometer component of the combined monitor presents a poor performance 
compared to other hip worn equipment, particularly at higher intensities during level walking and level 
jogging37. Therefore, the accuracy of accelerometer models from combined sensing may be limited due 
to the position of the monitor on the sternum38. Also the use of HR for EE prediction is not error free as 
its relation with PA intensity may be affected by several factors like age, sex, training state, mental stress, 
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ambient temperature, hydration, muscle mass involved in the activity, among others39, 40. In the current 
trial we were expecting that caffeine would increase HR and bias the results for PAEE and TEE. Though 
slightly higher PAEE and TEE values were observed under caffeine intake, our results suggested that 
there was no difference in either measured or estimated EE during the two different conditions. The 
combined monitor includes a built-in step–test protocol that is used for deriving the individual HR-PAI 
relationship in the field and EE is then calculated using ACC+HRstep. When the step test is not performed 
it is possible to select a model that uses the group calibration, which is an approximation for a range of 
individual fitness levels30.  
From the initial 30 participants, we lost data from 13 participants since ~11 complete days were 
required to validate this equipment under both conditions and we only included those with complete 
and valid days. Our power calculation suggested we would need at least 21 individuals with complete 
data at both time points to detect an effect of caffeine intake on energy expenditure. Thus, the lower 
sample size with complete data (N=17) may affect the possibility  to detect absolute differences in TEE 
and PAEE between conditions. However, when comparing estimated TEE and PAEE from combined 
sensing with that measured by DLW at both conditions the mean differences were fairly small  and 
approximately 8% for TEE and 11% for PAEE when using group calibration. While a larger sample 
size would allow detection of statistically significant differences between methods given the absolute 
mean differences are unchanged we consider the fairly small absolute and relative differences between 
methods as clinically acceptable. Further, the magnitude of differences between methods were 
unaffected by the caffeine treatment. Finally, even though we used a polar band placed on the chest 
(recently commercialized by CamNtech) instead of the standard ECG electrodes used in the 
aforementioned studies10, 14 these missing data may question the usefulness of this equipment for 
measuring PAEE during free-living for period longer than a week. 
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Conclusions  
Overall, the ingestion of a moderate dose of caffeine in low-users did not affect the validity of the 
combined ACC with HR, specifically the individual calibration in assessing TEE and PAEE in 
physically active males. Nevertheless, given the relatively larger limits of agreement, some caution 
should be used to interpret individual energy expenditure requirements.  
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Figures  
 
Figure 1 - Flow diagram of the progress through the phases of the cross-over randomized trial. 
 
Figure 2 - Upper panels: Regression between methods in assessing physical activity energy 
expenditure (PAEE) from the reference method (PAEEref) and PAEE using individual HR calibration 
from the combined motion sensor with heart rate monitoring (PAEEACC+HRstep). Lower panels: Bland-
Altman analysis of the agreement between methods in assessing PAEE, including the trend (r, 
coefficient of correlation) between the mean and the difference of both methods. 
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Table 1 – Baseline participant’s characteristics 
N=17 Mean  ± SD Range 
Age (years) 24.9 ± 4.8 20.0 - 38.0 
Height (cm) 176.0 ± 7.1 164.0 - 186.9 
Body weight (kg) 72.0 ± 8.5 62.0 - 90.2 
BMI (kg/m2) 23.2 ± 2.4 20.2 - 26.8 
FM (Kg) 11.9 ± 4.0 6.6 - 20.6 
FM (%) 16.5 ± 4.1 10.3 - 23.5 
FFM (kg) 59.3 ± 5.9 51.9 - 70.1 
Abbreviations: N, number of participants; SD, standard deviation; BMI, body mass index; FM, fat mass; FFM, fat-
free mass. 
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Table 2. Energy expenditure under caffeine or placebo treatments using the reference and the 
alternative methods 
N=17 Placebo Caffeine 
Heart Rate from indirect calorimetry (beats/min) 52 ± 6 54 ± 7 
REE indirect calorimetry (kJ/day) 5876 ± 956 6112 ± 1125 
REE Schofield (kJ/day) 7389 ± 519 
PAL from DLW 2.22 ± 0.45 2.28 ± 0.48 
TEE from reference † (kJ/day) 12875 ± 2373 13616 ± 2198 
TEE from Actiheart* (kJ/day)   
ACC+HRstep 13282 ± 2178 (p=0.606) 14084 ± 2642 (p=0.578) 
ACC+HRgroup 13921 ± 2923 (p=0.261) 14701 ± 3180 (p=0.256) 
HRflex 16806 ± 3578 (p<0.001) 17895 ± 4443 (p=0.001) 
ACC 10774 ± 1261 (p<0.001) 11082 ± 1396 (p<0.001) 
   
PAEE from reference ‡(kJ/day) 5712 ± 1747 6142 ± 1835 
PAEE from Actiheart* (kJ/day)   
ACC+HRstep 4565 ± 1516 (p=0.049) 5286 ± 2198 (p=0.227) 
ACC+HRgroup 5140 ± 2442 (p=0.438) 5842 ± 2709 (p=0.708) 
HRflex 7736 ± 2994 (p=0.022) 8717 ± 3807 (p=0.017) 
ACC 2397 ± 1042 (p<0.001) 2585 ± 1023 (p<0.001) 
   
   
Abbreviations: N, number of participants; PAL, physical activity level; REE, resting energy expenditure; TEE, total energy 
expenditure; PAEE, physical activity energy expenditure 
† TEE assessed by doubly labeled water  
‡ PAEE assessed by doubly labeled water and indirect calorimetry, assuming that the thermogenic effect of food is 10%of TEE 
(PAEE = TEE – (REE+0.1TEE) 
*Models of energy expenditure prediction from Actiheart: ACC+HRstep - individual HR calibration model (Group Cal 
JAP2007/Step HR,) with HR and accelerometry data; ACC+HRgroup - group HR calibration model (Group Cal JAP2007) with HR 
and accelerometry data; HRflex – using the individual HR calibration model (Group Cal JAP2007/Step HR) with HR data; ACC - 
ACC: using accelerometry data. 
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Table 3. Validity of the energy expenditure models from the combined HR and motion sensor monitor, under placebo treatment 1 
 Regression analysis CCC analysis Agreement analysis 
 r2 see CCC ρ Cb Bias Limits  Trend  
Total Energy Expenditure (kJ/day)* 
ACC+HRstep 0.82 a) 1028 0.89 0.9077 0.9797 406.6 -1545.7 2359.0 -0.20 0.439 
ACC+HRgroup 0.73 a) 1268 0.77 0.8558 0.9046 1045.1 -1929.5 4019.8 0.38 0.137 
HRflex 0.80 a) 1098 0.44 0.8941 0.4874 3930.1 397.2 7462.9 0.69 0.002 
ACC 0.43 a) 1847 0.33 0.6576 0.5022 -2101.8 -5655.0 1451.5 -0.67 0.003 
 
Physical Activity Energy Expenditure(kJ/day)* 
ACC+HRstep 0.66 a) 1214 0.67 0.8106 0.8229 -1146.9 -3457.3 1163.5 -0.26 0.314 
ACC+HRgroup 0.50 a) 1465 0.67 0.7073 0.9481 -572.3 -4000.3 2855.7 0.27 0.297 
HRflex 0.63 a) 1265 0.55 0.7922 0.6929 2024.1 -1267.2 5675.5 0.56 0.020 
ACC 0.17 1886 0.10 0.4152 0.2492 -3315.2 -6917.6 287.2 -0.61 0.009 
           
*Models of energy expenditure prediction from Actiheart: ACC+HRstep - individual HR calibration model (Group Cal JAP2007/Step HR, with HR and accelerometry data; ACC+HRgroup - group HR 2 
calibration model (Group Cal JAP2007) with HR and accelerometry data; HRflex – using the individual HR calibration model (Group Cal JAP2007/Step HR) with HR data; ACC - ACC: using 3 
accelerometry data. 4 
a) Significant associations (p<0.05) 5 
Abbreviations: r2, coefficient of determination; see, standard error of estimation; CCC, concordance correlation coefficient; ρ, precision; Cb, accuracy) 6 
 7 
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 1 
Table 4. Validity of the energy expenditure models from the combined HR and motion sensor monitor, under caffeine treatment 2 
 Regression analysis CCC analysis Agreement analysis 
 r2 see CCC Ρ Cb Bias Limits Trend  
Total Energy Expenditure (kJ/day)* 
ACC+HRstep 0.76 a) 1107 0.84 0.8730 0.9644 467.9 -2066.4 3002.2 0.35 0.163 
ACC+HRgroup 0.64 a) 1368 0.69 0.7980 0.8632 1085.6 -2729.9 4901.0 0.53 0.028 
HRflex 0.74 a) 1147 0.38 0.8629 0.4436 4279.4 -1166.0 9724.8 0.83 <0.001 
ACC 0.50 a) 1603 0.32 0.7081 0.4513 -2533.9 -5592.3 524.4 0.55 0.021 
Physical Activity Energy Expenditure(kJ/day)* 
ACC+HRstep 0.64 a) 1155 0.71 0.7928 0.8986 -856.0 -3487.5 1775.5 0.26 -0.261 
ACC+HRgroup 0.51 a) 1333 0.65 0.7110 0.9204 -300.1 -4038.5 3438.3 0.49 -0.044 
HRflex 0.64 a) 1133 0.45 0.8014 0.5611 2574.4 -2486.4 7635.1 0.80 <0.001 
ACC 0.39 a) 1484 0.13 0.6220 0.2102 -3557.7 -6383.5 -731.8 -0.62 0.008 
           
*Models of energy expenditure prediction from Actiheart: ACC+HRstep - individual HR calibration model (Group Cal JAP2007/Step HR, with HR and accelerometry data; ACC+HRgroup - group HR 3 
calibration model (Group Cal JAP2007) with HR and accelerometry data; HRflex – using the individual HR calibration model (Group Cal JAP2007/Step HR) with HR data; ACC - ACC: using 4 
accelerometry data. 5 
a) Significant associations (p<0.05) 6 
Abbreviations: r2, coefficient of determination; see, standard error of estimation; CCC, concordance correlation coefficient; ρ, precision; Cb, accuracy) 7 
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